R

Remed Co Ltd
KOSDAQ:302550

Watchlist Manager
Remed Co Ltd
KOSDAQ:302550
Watchlist
Price: 2 965 KRW 3.13% Market Closed
Market Cap: 93.4B KRW
Section:
 

Relative Value

The Relative Value of one Remed Co Ltd stock under the Base Case scenario is 2 021.5 KRW. Compared to the current market price of 2 965 KRW, Remed Co Ltd is Overvalued by 32%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
2 021.5 KRW
Overvaluation 32%
Relative Value
Price
R
Worst Case
Base Case
Best Case

Valuation Multiples

3.8
P/S
P/S
Price to Sales
3.8
vs History
36
vs Industry
24
Median 3Y
3.9
Median 5Y
0
Industry
2.4
More Details
28
P/E
P/E
Price to Earnings
28
vs History
15
vs Industry
5
Median 3Y
13.9
Median 5Y
0.2
Industry
22.9
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
26
Median 3Y
10.3
Median 5Y
0.1
Industry
14.7
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
17
Median 3Y
-4.7
Median 5Y
-5.3
Industry
21.4
More Details
2.3
P/B
P/B
Price to Book Value
2.3
vs History
39
vs Industry
31
Median 3Y
2.5
Median 5Y
0.1
Industry
2.3
More Details
3.3
EV/S
EV/S
Enterprise Value to Sales
3.3
vs History
36
vs Industry
22
Median 3Y
3.7
Median 5Y
-0.6
Industry
2.6
More Details
5.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
5.5
vs History
38
vs Industry
19
Median 3Y
6.2
Median 5Y
-1.2
Industry
5.3
More Details
44.7
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
44.7
vs History
15
vs Industry
8
Median 3Y
30.9
Median 5Y
-7.5
Industry
12.3
More Details
187.2
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
187.2
vs History
11
vs Industry
6
Median 3Y
48.3
Median 5Y
-15
Industry
17.2
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
26
Median 3Y
10
Median 5Y
-5.1
Industry
15
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
26
Median 3Y
11
Median 5Y
-7.4
Industry
19
More Details
2
EV/IC
EV/IC
Enterprise Value to IC
2
vs History
30
vs Industry
38
Median 3Y
2
Median 5Y
-0.3
Industry
1.9
More Details

Multiples Across Competitors

Competitors Multiples
Remed Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
Remed Co Ltd
KOSDAQ:302550
91.6B KRW 3.8 28 44.7 187.2
US
Abbott Laboratories
NYSE:ABT
219B USD 5 15.7 20 27.8
US
Intuitive Surgical Inc
NASDAQ:ISRG
210.2B USD 21.9 76.5 58.7 71.6
US
Boston Scientific Corp
NYSE:BSX
144.7B USD 7.5 51.9 30.3 41.2
US
Stryker Corp
NYSE:SYK
140.5B USD 5.8 47.7 23.2 28.2
IE
Medtronic PLC
NYSE:MDT
125B USD 3.6 26.2 14.8 21.4
DE
Siemens Healthineers AG
XETRA:SHL
51.9B EUR 2.2 24.2 13.6 19.2
US
Becton Dickinson and Co
NYSE:BDX
57.9B USD 2.6 34.5 12.7 21.6
US
IDEXX Laboratories Inc
NASDAQ:IDXX
57.1B USD 13.7 55.5 39.9 44.2
US
Edwards Lifesciences Corp
NYSE:EW
49.4B USD 8.4 36.1 25.8 28.3
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
39.8B USD 2 17.9 13.3 16.1

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 308,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.